Zhejiang Shouxiangu Pharmaceutical Co Ltd
SSE:603896

Watchlist Manager
Zhejiang Shouxiangu Pharmaceutical Co Ltd Logo
Zhejiang Shouxiangu Pharmaceutical Co Ltd
SSE:603896
Watchlist
Price: 21.37 CNY -0.6%
Market Cap: 4.2B CNY
Have any thoughts about
Zhejiang Shouxiangu Pharmaceutical Co Ltd?
Write Note

Zhejiang Shouxiangu Pharmaceutical Co Ltd
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Zhejiang Shouxiangu Pharmaceutical Co Ltd
Retained Earnings Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
Zhejiang Shouxiangu Pharmaceutical Co Ltd
SSE:603896
Retained Earnings
ÂĄ1.1B
CAGR 3-Years
24%
CAGR 5-Years
25%
CAGR 10-Years
N/A
Hengan International Group Company Ltd
HKEX:1044
Retained Earnings
ÂĄ20.7B
CAGR 3-Years
3%
CAGR 5-Years
4%
CAGR 10-Years
5%
S
Shanghai Flyco Electrical Appliance Co Ltd
SSE:603868
Retained Earnings
ÂĄ1.8B
CAGR 3-Years
0%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Proya Cosmetics Co Ltd
SSE:603605
Retained Earnings
ÂĄ3.6B
CAGR 3-Years
31%
CAGR 5-Years
33%
CAGR 10-Years
N/A
By-health Co Ltd
SZSE:300146
Retained Earnings
ÂĄ4.4B
CAGR 3-Years
28%
CAGR 5-Years
15%
CAGR 10-Years
N/A
G
Giant Biogene Holding Co Ltd
HKEX:2367
Retained Earnings
ÂĄ2.7B
CAGR 3-Years
80%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Zhejiang Shouxiangu Pharmaceutical Co Ltd
Glance View

Market Cap
4.3B CNY
Industry
Consumer products

Zhejiang Shouxiangu Pharmaceutical Co., Ltd. engages in the breeding, cultivation, processing, and sale of Chinese herbal pieces and health food. The company is headquartered in Jinhua, Zhejiang and currently employs 1,026 full-time employees. The company went IPO on 2017-05-10. The firm's main products include ganoderma lucidum spore powder, Tiepi Fengdou granule, ganoderma extract products and fresh dendrobium officinales, among others. The firm mainly operates its businesses in domestic markets through wholesaling and direct sales.

Intrinsic Value
33.69 CNY
Undervaluation 37%
Intrinsic Value
Price

See Also

What is Zhejiang Shouxiangu Pharmaceutical Co Ltd's Retained Earnings?
Retained Earnings
1.1B CNY

Based on the financial report for Sep 30, 2024, Zhejiang Shouxiangu Pharmaceutical Co Ltd's Retained Earnings amounts to 1.1B CNY.

What is Zhejiang Shouxiangu Pharmaceutical Co Ltd's Retained Earnings growth rate?
Retained Earnings CAGR 5Y
25%

Over the last year, the Retained Earnings growth was 14%. The average annual Retained Earnings growth rates for Zhejiang Shouxiangu Pharmaceutical Co Ltd have been 24% over the past three years , 25% over the past five years .

Back to Top